Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Neonatal Perinatal Med ; 16(4): 689-692, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-38043021

RESUMO

Clinical decision support (CDS) has shown a positive effect on physicians. There is variability among physicians about using postnatal steroids (PNS) in preterm (PT) infants. It is, therefore, essential to develop tools supporting the decision to use PNS in PT infants. We propose a model using online tools such as CDS in deciding to use PNS in PT infants. We combined the online bronchopulmonary dysplasia (BPD) estimator and extubation success calculator tools to be used as a simple bedside tool assisting decisions about using PNS in ventilated PT infants.


Assuntos
Inteligência Artificial , Displasia Broncopulmonar , Recém-Nascido , Lactente , Humanos , Glucocorticoides/uso terapêutico , Lactente Extremamente Prematuro , Displasia Broncopulmonar/terapia , Esteroides/uso terapêutico , Respiração Artificial
2.
Public Health ; 173: 97-104, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31261032

RESUMO

OBJECTIVES: The objectives of this article are to highlight the properties of the Nipah virus (NiV) and discuss its epidemiological determinants. STUDY DESIGN: A review of conjectures, epidemiological and clinically related studies, and identification and discussion of preventive approaches is conducted. METHODS: A review of the current literature is performed going through online search engines: PubMed and Google Scholar. The search strategy was focused on two main components, first on the NiV ('Nipah' OR 'Nipah Virus') and subsequently on its epidemiology, including determinants and preventive measures ('Epidemiology/determinants' OR 'Epidemiology/prevention'). RESULTS: NiV infection is an emerging zoonotic infectious disease causing sporadic outbursts in many developing countries within Asia, Africa, and South America. Pteroid bats are the natural reservoirs, but human-to-human transmission is possible. Clinical course ranges from non-specific influenza-like symptoms to rapidly progressive respiratory and neurologic complications. Vector control has been challenging because of its widely distributed ecological niche. Currently, no definitive treatment protocols are available in humans, but profound breakthrough in vaccine technology and successful equine vaccines has shown the way for the development of NiV vaccine and immunization in the near future. CONCLUSIONS: The NiV poses a significant public health risk because of its intricate transmission cycle, unpredictable viral course, murky management protocol, and unavailability of vaccine. Complicated by emergence and subsequent reemergence, prevention and containment are the two most important public health promotion strategies. Early anticipation, intergovernmental preparedness and cooperation, and surveillance of zoonotic infections still remain the key to mitigate the risk.


Assuntos
Surtos de Doenças , Infecções por Henipavirus/epidemiologia , Vírus Nipah , Animais , Surtos de Doenças/prevenção & controle , Infecções por Henipavirus/prevenção & controle , Humanos , Vacinas Virais , Zoonoses/epidemiologia , Zoonoses/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...